Accelerating Diagnostic Assay Development with TruCytes™

Precision-engineered cell mimics empower researchers and developers to optimize, validate, and assess the clinical utility of diagnostic assays.

In the rapidly evolving field of diagnostics, precision and reliability are non-negotiable.

Slingshot Biosciences’ TruCytes™—precision-engineered cell mimics—empower researchers and developers to optimize, validate, and ensure the clinical utility of diagnostic assays. From early development to widespread clinical adoption, TruCytes are designed to streamline workflows, reduce variability, and enhance confidence in your diagnostic tools.

Accelerated Assay Development

Streamline the design and optimization of diagnostic assays with ready-to-use TruCytes that provide consistent, biologically relevant performance.

Precise
Validation

TruCytes ensure robust assay validation by mimicking the cellular phenotype and function critical to your diagnostic targets. Their reliability supports high sensitivity and specificity across platforms.

Simplified Clinical
Utility Studies

Enable faster and more reliable clinical utility studies with customizable TruCytes that standardize results across multiple instruments, protocols, and clinical sites.

Scalable for
Every Phase

Whether for early feasibility assessments or routine quality control, TruCytes scale to meet the demands of assay development, validation, and clinical adoption.

See how we helped Prolocor design the ideal control for their platelet FcγRIIa precision diagnostic test that quantifies FcγRIIa on the surface of platelets to guide clinical decision making.

“Clinicians need better tools to guide decision making on the choice of antiplatelet therapy in coronary artery disease patients, particularly after coronary stenting. The Prolocor pFCG® test will be an important asset as we tailor antiplatelet therapies to balance thrombotic and bleeding risk.”

Dominick J. Angiolillo, MD, PhD, FACC, FESC, FSCAI | Professor of Medicine, Chief, Division of Cardiology, Director, Thrombosis Research Center

University of Florida, College of Medicine-Jacksonville.

Applications for Diagnostics

Biomarker-Based Assays: Mimic biomarkers of interest to optimize assay performance and ensure accurate detection.
Flow Cytometry Diagnostics: Provide robust controls for flow cytometry-based assays to enhance sensitivity and reproducibility.
Molecular Diagnostics: Utilize TruCytes to validate sample preparation, reagent performance, and instrumentation in molecular diagnostic workflows.
Point-of-Care Tests: Facilitate the validation and deployment of point-of-care diagnostic tests with reliable, reproducible cell mimics.
Quality Control: Incorporate TruCytes into routine QC processes to ensure ongoing assay reliability.

The Slingshot Biosciences Advantage

Customizable to Your Needs

TruCytes can be engineered to replicate specific cell phenotypes and functions critical to your diagnostic assays, ensuring a precise fit for your requirements.

Consistency Across Platforms

Eliminate variability with TruCytes’ lot-to-lot consistency, enabling standardization across multiple assay platforms and sites.

Expert Support at Every Step

Our team of Field Application Scientists partners with you throughout the assay development process, from feasibility testing to clinical deployment, ensuring seamless integration and maximum impact.

Unlock the Full Potential of Your Diagnostic Assays

Slingshot Biosciences is committed to advancing diagnostic innovation by delivering precision tools that elevate assay performance and reliability. With TruCytes™, you gain more than a product—you gain a partner dedicated to your success.

Contact Us Today

Learn how TruCytes™ can transform your diagnostic assay development, validation, and clinical utility. Together, we can set a new standard in diagnostics.